The trajectory of Viagra presents a challenging picture for investors. While the initial introduction generated substantial gains, the lapse of its exclusive rights opened the avenue to off-brand alternatives, dramatically eroding market share. This poses a unique risk for firms banking on similar blockbuster offerings, suggesting that a blind stak

The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in revenue , its exclusivity period created a flood of knock-off medications, significantly diminishing its click here position . While some firms may seek to capitalize on male sexual dysfunction, the pres